AMPE

Ampio Pharmaceuticals (AMPE)

About Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$7.47
52 Week Low
$0.00
Market cap
2,500
Dividend yield
0.00%
Volume
416
Avg. volume
824
P/E ratio
.00

Ampio Pharmaceuticals News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$7.47
52 Week Low
$0.00
Market cap
2,500
Dividend yield
0.00%
Volume
416
Avg. volume
824
P/E ratio
.00